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Melanogenesis is a process which forms new pigment and is considered to have
the function of controlling the overall pigmentation of higher animals, including
man. An enhancement of melanogenesis is observed when a prolonged in vivo ad-
ministration of melanocyte-stimulating hormone (MSH) is given to test animals.
The mechanism through which MSH induces melanogenesis in vivo is not well
understood at present. Since tyrosinase is a key enzyme involved in biosynthesis
of melanin pigment and is present in appreciable quantities in pigmentary system,
it seems likely that it participates in the action of MSH on pigment formation.
This communication reports the in vivo effect of MSH on tyrosinase activity and
melanogenesis of two different pigmentary systems, namely, the benign skin
melanocytes of Rana pipiens frog and malignant B-16 mouse melanoma. A uniform
hypothesis on the mechanism of induction of melanogenesis by this hormone is
postulated.
INDUCTION OF MELANOGENESIS IN RANA PIPIENS FROGS
Male Rana pipiens were used to investigate the in vivo effects of MSH on tyro-
sinase activity and melanogenesis. The detail of the study has been described else-
where (1). The in vivo responses of Rana pipiens skin melanocytes to the action
of MSH are slow, if the transient darkening of skin coloration is disregarded. After
the second week of MSH administration, it became noticeable that the treated frogs
remained darker than the control animals when the immediate action of MSH sub-
sided and the animals supposedly returned to their "normal" coloration. It was
also noted that the skin debris shed by the treated animals was darker. Both obser-
vations are consistent with an elevated rate of synthesis and turnover of melanin
in skin melanocytes.
When the isolated skin of these frogs were tested for their ability to darken and
lighten in response to external stimuli, two characteristic features were observed,
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the treated group had a lower reflectance reading at all stages of the experiment
and a narrower range of variation among individuals as compared to the control
animals. The results are shown in Figs. 1 and 2. The capacity of the skin of the
treated group to respond to external stimuli remained essentially unchanged, as
indicated by the unchanged increase and decrease in reflectance brought about by
washing with Ringer solution and by the action of MSH, respectively. These obser-
vations may be interpreted as indicating that there was an increase of melanin con-
tent of melanosomes but no significant increase in the number of melanosomes
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FIG. 1. In vitro responses toward washing with Ringer solution and MSH action of the
isolated Rana pipiens skin from the control group. The washing period consisted of 4 changes
of Ringer solution at 15-min intervals; the MSH period was 60 min under the action of
10 units of standard MSH in 20 ml of Ringer solution. Each point on the chart represents
the mean value of 4 locations on the body of the frog.
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FIG. 2. In vitro Responses toward washing with Ringer solution and MSH action of
the isolated Rana pipiens skin from the treated group, received daily injection of MSH
for 21 days. The same conditions as those indicated in Fig. 1 were employed.MSK ON TYROSINASE AND MELANOGENESIS
250
0 r 200
z
0
0
I50 I500
Z p >
z0 o <
p~~
2 z cr
I~~~~~~~~~I 0 Hz
~50. 50 > --2
w MSH INJECTION jNO INJECTION _
0 50 100
TIME IN DAYS
FIG. 3. Effect of long-term MSH treatment on the melanin content and tyrosinase activity
in the skin of Rana pipiens frogs.
or melanocytes. Moreover, these melanized melanosomes behaved normally toward
external stimuli after being in a dispersed state for long periods of time.
Tyrosinase of Rana pipiens skin is a soluble cytoplasmic protyrosinase which
requires activation by a proteolytic enzyme. Trypsin, chymotrypsin, and a fungal
protease (Streptomycetes griseus) were found equally effective, indicating that
the activation of the protyrosinase did not involve the cleavage of a specific type
of peptide bonds. A spectrophotometric procedure measuring the formation of
dopachrome from L-tyrosine was used to measure the tyrosinase activity of the
skin extract. Since trypsin was included in the assay mixture, therefore, the proce-
dure measured the total soluble tyrosinase activity regardless of the state of activa-
tion of the enzyme in the specimens. The melanin content of skin specimens was
measured spectrophotometrically by solubilizing the melanin in dilute alkali after
removal of proteins by peptic digestion. Figure 3 shows the melanin content and
tyrosinase activity of skin specimens obtained from frogs given daily injection of
MSH for 8 weeks, followed by a period of 8 weeks during which no injection
was given. The tyrosinase activity of the skin decreased while the rate of melanin
synthesis was elevated. An inverse relationship between the tyrosinase activity and
melanin content was observed. This finding supports the hypothesis that the admin-
istration of MSH may release a bound, intracellular proteolytic enzyme which acti-
vates the inactive protyrosinase. The tyrosinase molecule, once activated, attaches
itself to the protein matrix of a subcellular particle and initiates melanin synthesis,
leading to the MSH-induced melanogenesis. The conversion of the soluble proty-
rosinase to active tyrosinase bound to subcellular particles causes a decrease of
the soluble protyrosinase content of the skin as measured by the dopachrome pro-
cedure under the conditions used.
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INDUCTION OF MELANOGENESIS IN B-16 MOUSE MELANOMA
Female C57BL/6J mice of the same age (6-9 weeks old) were used in this
study (2). The pigmentary system of B-16 mouse melanoma was found to be more
responsive toward the action of MSH than amphibian skin melanocytes. Striking
changes were observed in relatively short periods of time. On account of the short
life span of the animal carrying B-16 melanoma, experiments in this study were
not carried beyond 30 days after the implantation of the tumor. Mouse melanoma
tyrosinase is tightly bound to melanosomes and is not readily solubilized by com-
mon laboratory aqueous buffers. Due to its insoluble nature, it was not possible
to measure the enzyme activity by the spectrophotometric procedure. For this rea-
son, we used a modification of the hydroxylation procedure (3) which is amenable
to the measurement of particulate tyrosinase.
Studies were carried out to investigate the time course of induction of melano-
genesis by MSH. The mice received a single injection of 2 mg of a-MSH at the
beginning of the experiment and, thereafter, received no further injection. A sig-
nificant increase of tyrosinase activity and melanogenesis of the tumor was ob-
served. There were, however, marked differences in the rate and extent of enzyme
induction between experiments. The time in which tyrosinase activity and melano-
genesis reached the maximum value also varied widely. Figure 4 represents the
results of a typical series of experiments. The initial increase of the enzyme activity
appeared between 1 and 2 days after the injection of a-MSH and reached a maxi-
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FIG. 4. Time course of induction of tyrosinase and melanogenesis in B-l6 melanoma pro-
duced by one injection of 2 mg of a-MSH to mice bearing this tumor. (0 0) Tyrosinase
activity of a-MSH-treated tumor; (0- 0---) tyrosinase activity of control tumor;
(X- X) melanin content of a-MSH treated tumor; (X---X) melanin content of control
tumor.
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TABL,E 1
EFFECTS OF a- ISII ON TYROSINASE ACTIVITY AND MlELANIN CONTENT OF B-16 MELANOMA
'ltyrosiniase activity MIelanin content
No. No. of (Ai moles 3HOH1/hr/mg DNA) (01)475/mg DNA)
Expt Dose per First injec-
no. (mg) group injectiona tionsb BiSA a-NISH Inicrease BSA a-MISH Increase
1 2 6 Day I 12 0.195 1.720 1.525
19 0.168 1.730 1.562
2 2 6 Day 1 12 0.133 1.800 1.667 0.77 2.90 2.13
19 0.1.52 2.190 2.038 1.25 4.81 3.56
3 0.5 4 Day 8 2 0.472 0.526 0.054 0.42 0.85 0.43
4 0.416 0.745 0.3.29 0.60 1.75 1.15
6 0.548 0.942 0.49)4 0.89 2.13 1.24
9 0.627 1.849 1.22-2 1.85 4.19 2.34
12 0.608 1.968 1.360 1.44 3.76 2.33
21 0.461 2.060 1.559 2.50 5.14 2.64
a Day 1 was defined as 24 hr after tumor implantation.
b The animals were sacrificed 24 hr after the last inijection.
TABLE 2
SUBCEILLULAIR DISTRIBUTION OF TYROSINASE ACTIVITY OF B-16 MELANOANIA
Tyrosinase activity (,umoles 3HOH1/hr/mg tumor DNA equivalent)-
Injections
2 4 6 9 12 21
BSA a-MISH BSA a-NISH BSA a-MISH BSA a-MISH BSA a--ISH lIS a-MISH
Whole 0.472 0.526 0.416 0.745 0.548 0.942 0.627 1.849 0.608 1.968 0.461 2.06
Fraction 1 0.070 0.067 0.095 0.125 0.050 0.071 0.086 0.180 0.091 0.260 0.051 0.257
Fraction 2 0.281 0.312 0.226 0.450 0.261 0.462 0.338 0.976 0.343 1.109 0.243 1.102
Fraction 3 0.099 0.123 0.060 0.128 0.166 0.300 0.141 0.529 0.105 0.415 0.108 0.503
Fraction 4 0.023 0.04 0.031 0.042 0.071 0.103 0.062 0.164 0.068 0.184 0.059 0.192
a The tyrosinase activity of all subcelltilar fractions were normalized to 100%, recovery of the fractionation. 'I'he average
recovery was 90%/ with a range of 77-110%';.
mum value on the 5th day. Thereafter, the enzyme activity dropped sharply to ap-
proximately twice the control level on the 9th day when the experiment was termi-
nated. The time course of melanogenesis of the tumor followed that of the enzyme
with a lag period of 2 days. It is of interest to note that the melanin content of
the tumor fell rapidly to nearly the control value after the maximum melanogenesis
was reached, indicating a high turnover rate of melanin in the tumor pigmentary
system.
When the daily injection of a-MSH was maintained over a period of time, more
extensive induction of melanogenesis and enzyme activity occurred as shown in
Table 1. The results suggest that the induction of melanogenesis was proportional
to the dosage as well as to the length of administration of a-MSH. The subcellular
distribution of tyrosinase activity was investigated by fractionating the tumor into
subcellular fractions according to the procedure of Seiji et al. (4). The results are
shown in Table 2. The tyrosinase activity of all subcellular fractions was increased
manifold by the administration of a-MSH and more than 50% of the total increaase
of tyrosinase activity was found in Fraction 2, which contained the major portion
of mature melanosomes. Moreover, there was a considerable amount of enzyme
activity in Fraction 4, the soluble fraction of the tumor, indicating that there are
2 types of tyrosinase activities:one is attached to subcellular particles and the other
is a soluble enzyme. These observations are compatible with the hypothesis on
the biosynthesis of melanosomes postulated by Seiji et al. (4). Figure 5 showsLEE AND LEE
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FIG. 5. Percentage distribution of tyrosinase activity in subcellular fractions from a-MSH-
treated and control B-16 melanoma after 2, 4, 6, 9, 12, and 21 injections. The dosage used
was 0.5 mg of a-MSH or BSA per animal. (0 O) a-MSH-treated tumor; (X ---- X)
control tutmor.
the percent of the total tyrosinase activity of the tumor contributed by each sub-
cellular fraction at various stages of the experiment. The most striking feature of
these diagrams is that there was no remarkable difference between the treated and
the control animals. In other words, the subcellular distribution pattern of tyro-
sinase activity was not significantly altered by the hormone treatment, although
the tyrosinase activity of each of these subcellular fractions was increased manifold.
The results of time-course studies strongly suggested that the action of a-MSH
on the melanogenesis of mouse melanoma was mediated through an increase of
tyrosinase activity of the tumor. The question arises as to whether the increase
of tyrosinase activity came about by an increased rate of synthesis of the enzyme
or by other means. If an increased synthesis did take place, it would be expected
that a soluble tyrosinase was synthesized, and these tyrosinase molecules would
orient themselves with structural proteins to form premelanosomes and melano-
somes. Thus, we should find a remarkable increase of tyrosinase activity in the
soluble fraction of the tumor at the onset of induction of the enzyme and a subse-
quent gradual shift of the increase to the "small" and "large" granule fractions.
We observed a universal increase and an unaltered distribution pattern of tyro-
sinase activity among all subcellular fractions of the tumors, at early as well as
late stages of the experiment, ruling out the possibility that an increased synthesis
of the enzyme took place. Since the existence of a tyrosinase inhibitor, which may
act as a regulator of the melanogenesis of the tumor, has been confirmed by several
investigators (5-7), it is tempting to speculate that the administration of a-MSH
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may release an "activator" which counteracts the tyrosinase inhibitor to activate
the tyrosinase activity of the tumor.
Based on these considerations, a working hypothesis may be formulated as
follows: In both pigmentary systems, the action of MSH is mediated through an in-
crease of tyrosinase activity. In amphibian-skin pigmentary system, the administra-
tion of MSH may cause a slight physiochemical change in the intracellular environ-
ments leading to the release of a bound proteolytic enzyme, which in turn activates
the soluble protyrosinase. The tyrosinase, once activated, attaches itself to the pro-
tein matrix of a melanosome and initiates melanin synthesis. This scheme is con-
sistent with the observation that, during MSH-induced melanogenesis in Rana
pipiens, a decrease in the content of soluble protyrosinase of the skin occurred.
On the other hand, the tyrosinase of mouse melanoma exists in a partially inhibited
state under the influence of an intracellular tyrosinase inhibitor, and the administra-
tion of MSH may trigger the release of an "activator" which counteracts the in-
hibitor, leading to the activation of inhibited tyrosinase. This is consistent with
the observation that there was a universal increase but an unaltered distribution
pattern of tyrosinase activity among all subcellular fractions of the tumor during
the entire period of administration of the hormone. There is ample evidence that
intracellular cyclic AMP is a mediator of the transient action of MSH, involving
the dispersion of melanosomes to produce skin darkening in fish and amphibians.
It was also observed that MSH activated in vitro the adenylcylase system of
melanoma (8). Whether this enzyme system also plays a role in the in vivo MSH-
induced melanogenesis is not known at present.
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